Breaking News Instant updates and real-time market news.

MCRB

Seres Therapeutics

$10.95

-0.05 (-0.45%)

09:16
01/11/17
01/11
09:16
01/11/17
09:16

Seres still has major opportunities after SER-109 failure, says Cantor

Cantor analyst Bill Tanner says that the failure of the Phase 2 trial of Seres' SER-109 for C. difficile infection, or CDI, "was disappointing." However, the analyst believes that the CDI treatment "mostly represents proof of concept" and that the company has "far greater opportunities" ahead of it. He keeps a $16 price target and an Overweight rating on the shares.

MCRB Seres Therapeutics
$10.95

-0.05 (-0.45%)

08/01/16
BOFA
08/01/16
DOWNGRADE
BOFA
Neutral
Seres Therapeutics downgraded to Neutral from Buy at BofA/Merrill
08/01/16
LEER
08/01/16
NO CHANGE
Target $12
LEER
Outperform
Seres Therapeutics price target lowered to $12 from $43 at Leerink
Leerink analyst Joseph Schwartz lowered his price target for Seres Therapeutics to $12 from $43 following the company's "surprisingly disappointing" Phase 2 ECOSPOR data, investigating SER-109 in multiply recurrent Clostridium difficile infection, or rCDI, patients. Further, the analyst says that uncertainty for SER-109 raises negative read-through on other follow-on candidates, such as SER-287 for the treatment of mild-to-moderate Ulcerative Colitis and SER-262 in primary CDI. Leerink has an Outperform rating on the shares.
08/12/16
FBRC
08/12/16
NO CHANGE
Target $23
FBRC
Outperform
Seres Therapeutics recent selloff overdone, says FBR Capital
FBR Capital analyst Vernon Bernardino views the selloff in shares of Seres Therapeutics (MCRB) since July 29 as overdone. After the SER-109 Phase II ECOSPOR clinical study in recurrent Clostridium difficile infection did not achieve its endpoint, the analyst cut his price target for the shares to $23 from $43. He points out, however, that development of the company's other clinical-stage assets are partnered with Nestle (NSRGY). Seres' four other collaborations also represent upside potential in the stock, Bernardino tells investors in a research note. He reiterates an Outperform rating on Seres.
12/16/16
CANT
12/16/16
INITIATION
Target $16
CANT
Overweight
Seres Therapeutics initiated with an Overweight at Cantor
Cantor Fitzgerald analyst William Tanner started Seres Therapeutics with an Overweight rating and $16 price target.

TODAY'S FREE FLY STORIES

C

Citi

$66.58

-0.02 (-0.03%)

06:19
08/21/17
08/21
06:19
08/21/17
06:19
Hot Stocks
David Tenney says has left Citi after four years »

David Tenney, formerly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$910.67

-0.31 (-0.03%)

, GOOGL

Alphabet Class A

$926.18

-1.48 (-0.16%)

06:18
08/21/17
08/21
06:18
08/21/17
06:18
Hot Stocks
Google expected to release Android O today »

Google is expected to…

GOOG

Alphabet

$910.67

-0.31 (-0.03%)

GOOGL

Alphabet Class A

$926.18

-1.48 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

WFC

Wells Fargo

$51.68

-0.12 (-0.23%)

06:17
08/21/17
08/21
06:17
08/21/17
06:17
Periodicals
Elizabeth Warren criticizes Wells Fargo's board changes, BI says »

After Wells Fargo named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 12

    Oct

  • 15

    Jan

MSFT

Microsoft

$72.49

0.09 (0.12%)

06:16
08/21/17
08/21
06:16
08/21/17
06:16
Periodicals
Microsoft's Xbox One X to launch on November 7, Business Insider reports »

Microsoft's upcoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

GE

General Electric

$24.55

-0.2 (-0.81%)

06:09
08/21/17
08/21
06:09
08/21/17
06:09
Periodicals
Jeff Immelt becomes front-runner to head Uber, Recode says »

Former General Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 02

    Oct

GS

Goldman Sachs

$222.15

0.73 (0.33%)

, C

Citi

$66.58

-0.02 (-0.03%)

06:08
08/21/17
08/21
06:08
08/21/17
06:08
Periodicals
Goldman Sachs receives approval to trade equities in Saudi Arabia, Reuters says »

Goldman Sachs (GS) has…

GS

Goldman Sachs

$222.15

0.73 (0.33%)

C

Citi

$66.58

-0.02 (-0.03%)

CS

Credit Suisse

$14.88

0.18 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

KOS

Kosmos

$6.91

0.16 (2.37%)

06:05
08/21/17
08/21
06:05
08/21/17
06:05
Hot Stocks
Kosmos announces admission to trading on London Stock Exchange »

Kosmos Energy is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$0.60

0.0098 (1.66%)

06:03
08/21/17
08/21
06:03
08/21/17
06:03
Hot Stocks
ContraVir Pharmaceuticals issued new U.S. patent for expansion of cyclophilin »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

T

AT&T

$37.37

-0.23 (-0.61%)

, TWX

Time Warner

$101.19

-0.42 (-0.41%)

06:03
08/21/17
08/21
06:03
08/21/17
06:03
Periodicals
AT&T's proposed Time Warner takeover reaches late-stage point, WSJ reports »

The review of…

T

AT&T

$37.37

-0.23 (-0.61%)

TWX

Time Warner

$101.19

-0.42 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

ADP

ADP

$104.41

-0.27 (-0.26%)

06:01
08/21/17
08/21
06:01
08/21/17
06:01
Hot Stocks
ADP board rejects Pershing Square nominees for 2017 annual meeting »

ADP announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

SPX

S&P 500

06:00
08/21/17
08/21
06:00
08/21/17
06:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$22.93

-0.1 (-0.43%)

05:59
08/21/17
08/21
05:59
08/21/17
05:59
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$122.30

-0.19 (-0.16%)

05:58
08/21/17
08/21
05:58
08/21/17
05:58
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$32.21

-0.56 (-1.71%)

05:58
08/21/17
08/21
05:58
08/21/17
05:58
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$14.92

-0.02 (-0.13%)

05:57
08/21/17
08/21
05:57
08/21/17
05:57
Hot Stocks
KBR awarded PMC contract by OMV Offshore Abu Dhabi GmbH »

KBR announced it has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.02

-0.03 (-0.17%)

05:57
08/21/17
08/21
05:57
08/21/17
05:57
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$26.95

0.37 (1.39%)

05:57
08/21/17
08/21
05:57
08/21/17
05:57
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$61.01

0.04 (0.07%)

05:57
08/21/17
08/21
05:57
08/21/17
05:57
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$13.30

-0.36 (-2.64%)

05:55
08/21/17
08/21
05:55
08/21/17
05:55
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$73.89

2.39 (3.34%)

05:55
08/21/17
08/21
05:55
08/21/17
05:55
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$21.25

-1.03 (-4.62%)

05:55
08/21/17
08/21
05:55
08/21/17
05:55
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$70.66

2.42 (3.55%)

05:55
08/21/17
08/21
05:55
08/21/17
05:55
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$9.97

0.35 (3.64%)

05:54
08/21/17
08/21
05:54
08/21/17
05:54
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$29.46

0.36 (1.24%)

05:53
08/21/17
08/21
05:53
08/21/17
05:53
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$26.11

0.44 (1.71%)

05:53
08/21/17
08/21
05:53
08/21/17
05:53
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.